Increased peritoneal permeability to albumin in streptozotocin diabetic rats

Kidney International

Volumn 49, Issue 3, 1996, Pages 705-714

  Shostak, Avshalom ^a   Gotloib, Lazaro ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; EVANS BLUE; RUTHENIUM RED; STREPTOZOCIN;

ANIMAL EXPERIMENT; ARTICLE; DIABETES MELLITUS; ELECTRON MICROSCOPY; GLUCOSE BLOOD LEVEL; MESOTHELIUM; MICROVASCULATURE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0029943755     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.99     Document Type: Article

References (65)

1. BROWNLEE M, CERAMI A, VLASSARA H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
2. PARVING HH: Increased microvascular permeability to plasma proteins in short and long-term juvenile diabetes. Diabetes 25(Suppl 2):884-889, 1976
3. WILLIAMSON JR, KILO C: Capillary basement membranes in diabetes. Diabetes 32:96-100, 1983
4. ROHRBACH DH, HASSELL JR, KLECHMAN HK, MARTIN GR: Alterations in basement membrane (heparan sulfate) proteoglycan in diabetic mice. Diabetes 31:185-188, 1982
5. COHEN MP, KLEPSER M, WU VY: Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition. Diabetes 37:1324-1327, 1988
6. DECKERT T, FELAT-RASMUSSEN B, DJURUP R, DECKERT M: Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33:100-106, 1988
7. PARTHASARATHY N, SPIRO RG: Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31:738-141, 1982
8. WILLIAMSON JR, CHANG K, TILTON RG, PRATER C, JEFFREY JR, WEIGEL C, SHERMAN WR, EADES DM, KILO C: Increased vascular permeability in spontaneously diabetic B B/W rats and in rats with mild versus severe streptozotocin-induced diabetes: Prevention by aldose reductase inhibition and castration. Diabetes 36:813-821, 1987
9. CALDWELL RB, SLAPNICK SM, MCLAUGHLIN BJ: Decreased anionic sites in Bruch's membrane of spontaneous and drug-induced diabetes. Invest Ophthalmol Vis Sci 27:1691-1697, 1986
10. FISHER V: Modification of anionic sites in myocardial capillary basal laminae of diabetic rats. Microvasc Res 37:42-52, 1989
11. LEAK LV: Distribution of cell surface charges on mesothelium and lymphatic endothelium. Microvasc Res 31:18-30, 1986
12. GOTLOIB L, SHOSTAK A, JAICHENKO J: Ruthenium-Red stained anionic charges of rat and mice mesothelial cells and basal lamina: The peritoneum is a negatively charged dialyzing membrane. Nephron 48:65-70, 1988
13. GOTLOIB L, BAR-SELLA P, JAICHENKO J, SHOSTAK A: Ruthenium-Red stained polyanionic fixed charges in peritoneal microvessels. Nephron 47:22-28, 1987
14. KANWAR YS, FAROUHAR MG: Anionic sites in the glomerular base-ment membrane. J Cell Biol 81:137-153, 1979
15. GROND J, ELEMA JD: Localization and distribution of anionic charges in the glomerular mesangium of normal and nephrotic rats. Virchows Arch Cell Pathol 48:135-143, 1985
16. GOTLOIB L, SHOSTAK A, JAICHENKO J, GALDI P, FUDIN R: Cationized ferritin decorates the anionic fixed charges of mice mesenteric fenestrated capillaries. Nephron 55:419-422, 1990
17. GALDI P, SHOSTAK A, JAICHENKO J, FUDIN R, GOTLOIB L: Protamine sulfate induces enhanced peritoneal permeability to proteins. Nephron 57:45-51, 1991
18. HARALDSSON B: The peritoneal membrane acts as a negatively charged barrier restricting anionic proteins. (abstract) J Am Soc Nephrol 4:407, 1993
19. LLYPOLDT JK, HENDERSON LW: Molecular charge influences transperitoneal macromolecule transport. Kidney Int 43:837-844, 1993
20. DULANEY JT, HATCH FE: Peritoneal dialysis and loss of proteins: A review. Kidney Int 26:253-262, 1984
21. LEE HB, PARK MS, CHUNG SH, LEE YB, KIM KS, HWANG SD, MOON C: Peritoneal solute clearances in diabetics. Perit Dial Int 10:85-88, 1990
22. ZIMMERMAN AK, SABLAY LB, AYNEDIJIAN HS, BANK N: Increased peritoneal permeability in rats with alloxan-induced diabetes mellitus. J Lab Clin Med 103:720-730, 1984
23. KREDIET RT, ZUYDERHOUDT FMJ, BOESCHOTEN EW, ARISZ L: Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron 42:133-140, 1986
24. RAY PM, SCOTT WN: UK legislation relevant to keeping of laboratory animals, in The UFAW Handbook on the Care and Management of Laboratory Animals, edited by UFAW, Edinburg and London, Churchill-Livingston, 1972, p 1
25. KLENK DC, HERMANSON GT, KROHN RI, FUJIMOTO EK, MALLIA AK, SMITH PK, ENGLAND JD, WIEDMEYER HM, LITTLE RR, GOLDSTEIN DE: Determination of glycosylated hemoglobin by affinity chromatography: Comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clin Chem 28:2088-2094, 1982
26. GABBAY KH, HASTY K, BRESLOW JL, ELLISON RC, BUNN HF, GALLOP PM: Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 44:859-864, 1977
27. MAVER SM, STEFFERS MW, AZAR S, BROWN DM: Effects of dietary protein content in streptozotocin-diabetic rats. Kidney Int 35:48-59, 1989
28. BOLLAG DM, EDELSTEIN SJ: Protein Methods. New York, Wiley-Liss, 1991, p 50
29. PATTERSON CE, RHOALES RA, GARCIA JGN: Evans-blue as marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol 72:865-873, 1992
30. LANGE S, DELBRO DS, JENNISCHE E: Evans-blue permeation of intestinal mucosa in the rat. Scand J Gastroenterol 29:38-46, 1994
31. SIROIS MG, JANCAR S, BRAOUET P, PLANTE GE, SIROIS P: PAF increases vascular permeability in selected tissues: Effect of BN-S2021 and L655,240. Prostaglandins 36:631-644, 1988
32. ROGERS DF, BOSCHETTO P, BARNES PJ: Plasma exudation correlation between Evans-blue dye and radiolabeled albumin in guinea pigs airways in vivo. J Pharmacol Method 21:309-315, 1989
33. AUSPRUNK DB, BOUDREAU CL, NELSON DA: Proteoglycans in the microvasculature. II. Histochemical localization in proliferating capillaries of the rabbit cornea. Am J Pathol 103:367-375, 1981
34. SIMIONESCU M, SIMIONESCU N, PALADE GE: Partial chemical characterization of the anionic sites in the basal lamina of fenestrated capillaries. Microvasc Res 28:352-367, 1984
35. ALT JM, DEERBERG F, HACKBARTH HJ, STOLTE H: The study of urinary protein excretion in male rats as compared with human proteinuria. Contrib Nephrol 19:79-87, 1980
36. JANCAR S, DE GIACCOBI G, MARIANO M, SIROIS P, BRAQUET P: New Trends in Lipid Mediators Research. Edited by BRAQUET P, Basel, Karger, 1987, p 194
37. BROWN MA, ZAMMIT VC, LOWE SA: Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci 77:599-604, 1989
38. DUAN HJ, NAGATA T: Glomerular extracellular matrices and anionic sites in aging ddY mice: A morphometric study. Histochem 99:241-249, 1993
39. TRAP-JENSEN J, LASSEN NA: Increased capillary diffusion capacity for small ions in skeletal muscle in long-term diabetics. Scand J Clin Lab Invest 21:116-122, 1968
40. RECHTAND E, SMITH QR, LATKER CH, RAPAPORT SI: Altered blood-nerve barrier permeability to small molecules in experimental diabetes mellitus. J Neuropath Exp Neurol 46:302-314, 1987
41. RENKIN E: Capillary transport of macromolecules: Pores and other endothelial pathways. J Appl Physiol 58:315-325, 1985
42. DEEN WM, BRIDGES CR, BRENNER BM, MYERS BD: Heteroporous model of glomerular size selectivity: Application to normal and nephrotic humans. Am J Physiol 249:F374-F389, 1985
43. TAYLOR AE, GRANGER DN: Exchange of macromolecules across the microcirculation, in Handbook of Physiology (Section 2): The Cardiovascular System (vol IV), Microcirculation, edited by RENKIN EM, MICHEL CC, Bethesda, American Physiology Society, 1984, pp 467-520
44. BRENNER BM, HOSTETTER TH, HUMES HD: Molecular basis of proteinuria of glomerular origin. N Engl J Med 298:826-835, 1978
45. OLIVER JD, ANDERSON S, TROY JL, BRENNER BM, DEEN WM: Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol 3:214-228, 1992
46. HARALDSON B, EKHOLM C, RIPPE B: Importance of molecular charge for the passage of endogenous macromolecules across continuous capillary walls, studied by serum clearances of lactic dehydrogenase isoenzymes. Acta Physiol Scand 117:123-130, 1983
47. CHAKRABARTI S, MA N, SIMA AAF: Anionic sites in diabetic basement membranes and their possible role in diffusion barrier abnormalities in the BB-rat. Diabetologia 34:301-306, 1991
48. SHIMOMURA H, SPIRO RG: Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate, proteoglycan and laminin. Diabetes 36:374-381, 1987
49. ABRAHAMSON DR: Recent studies on the structure and pathology of basement membranes. J Pathol 149:257-278, 1986
50. SILBIGER S, CROWLEY S, SHAN Z, BROWNLEE M, SATRIANO J, SCHLONDORGG D: Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan change. Kidney Int 43:853-864, 1993
51. OLGEMOLLER B, SCHWAABE S, GERBITZ KD, SCHLEICHER ED: Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycans in proliferating cultured porcine mesangial cells. Diabetologia 35:183-186, 1992
52. KILO C, VOGLER N, WILLIAMSON JR: Muscle capillary basement membrane changes related to aging and to diabetes mellitus. Diabetes 21:881-905, 1972
53. YAGIHASHI S, GOTO Y, KAKIZAKI M, KASEDA N: Thickening of glomerular basement membrane in spontaneously diabetic rats. Diabetologia 15:309-312, 1978
54. VRACKO R, PECORARO RE, CARTER WB: (Overview article) Basal lamina of epidermis, muscle fibers, muscle capillaries, and renal tubules: Changes with aging and diabetes mellitus. Ultrastruct Pathol 1:559-574, 1980
55. OSTERBY-HANSEN R: Morphometric studies of the peripheral glomerular basement membrane in early juvenil diabetes. I. Development of the initial basement membrane thickening. Diabetologia 8:84-92, 1972
56. HASSLACHER C, REICHENBACHER R, GECHTER F, TIMPL R: Glomerular basement membrane synthesis and serum concentration of type IV collagen in streptozotocin-diabetic rats. Diabetologia 26:150-154, 1984
57. LI W, SHEN S, KHATAMI M, ROCKEY JH: Stimulation of retinal capillary pericyte protein and collagen synthesis in culture by high glucose concentration. Diabetes 33:785-789, 1984
58. CAGLIERO E, MAIELLO M, BOERI D, ROY S, LORENZI M: Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 82:735-738, 1988
59. ASHWORTH CT, ERDMANN RR, ARNOLD NJ: Age changes in the renal basement membrane of rats. Am J Pathol 36:165-179, 1960
60. MAHIOUT A, GOTZ E, REINHARD B: Intraperitoneal accumulation of advance glycosylation end products in CAPD patients. (abstract) Perit Dial Int 15(Suppl 1):S78, 1995
61. BROWNLEE M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835-1843, 1992
62. GHIGGERI GM, CANDIANO G, DELFINO G, BIANCHINI F, QUEIROLO C: Glycosyl albumin and diabetic microalbuminuria: Demonstration of an altered renal handling. Kidney Int 25:565-570, 1984
63. PIETRAVALLE P, MORANO S, CRISTINA G, DE ROSSI MG, MARIANI G, COTRONEO P, GHIRLANDA G, CLEMENTI A, ANDREANI D, DI MARIO U: Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance. Diabetes 40:1685-1690, 1991
64. PURTELL JN, PESCE AJ, CLYNE DH, MILLER WC, POLLAK VE: Isoelectric point of albumin: Effect on renal handling of albumin. Kidney Int 16:366-376, 1979
65. ISHIBASHI T, TANAKA K, TANIGUICHI Y: Disruption of blood-retinal barrier in experimental diabetic rats: An electron microscopic study. Exp Eye Res 30:401-410, 1980